Finnrick - Ensuring a Safer and More Transparent Supply Chain
Wuhan Wansheng Biotechnology

Wuhan Wansheng Biotechnology

Finnrick has tested 50 samples from Wuhan Wansheng Biotechnology across 3 products.

Finnrick Vendor Profile
to
C
E
Wuhan Wansheng Biotechnology
Tracking 3 products
50 total samples tested
Last test 18 Nov 2025

Take Action

Test My Sample
Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Products

Tests
Product
Rating
CountAvgMinMaxOldestMost Recent
Retatrutide
C
Okay
307.24.610.04 Aug 202518 Nov 2025
Tesamorelin
E
Bad
65.52.87.811 Aug 202529 Oct 2025
Tirzepatide
E
Bad
146.82.89.931 Aug 20254 Nov 2025

Most recent Wuhan Wansheng Biotechnology tests

Samples are tested in commercial labs

50

tests

3

products

Scores

AVG6.8MIN2.8MAX10.0

First

4 Aug 2025

Last

18 Nov 2025
Quantity
Test DateProductCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
18 Nov 2025RetatrutideView7.420mg17.000mg-15.0%99.80%July 15 2025No Label / Silver Crimp / Violet CapLab EPublic
17 Nov 2025RetatrutideView7.130mg28.100mg-6.3%99.72%(no batch ID)No Label / Silver Crimp / Clear Yellow CapLab EPublic
4 Nov 2025TirzepatideView7.810mg10.400mg+4.0%99.82%(no batch ID)No Label / Silver Crimp / White CapLab EPublic
3 Nov 2025RetatrutideView7.840mg39.500mg-1.3%99.80%(no batch ID)No Label / Silver Crimp / Red CapLab GPublic
30 Oct 2025TirzepatideView8.010mg10.990mg+9.9%99.70%9-22-25No Label / Silver Crimp / Gray CapLab GPublic
30 Oct 2025RetatrutideView8.910mg10.600mg+6.0%99.60%9-22-25No Label / Silver Crimp / Green CapLab GPublic
29 Oct 2025RetatrutideView8.010mg9.740mg-2.6%99.95%(no batch ID)No Label / Silver Crimp / Clear Blue CapLab EPublic

Corrections

5 Nov 2025: Retatrutide
These were remade and reanalyzed by Lab G. They traced the discrepancy to a likely human error during preparation.